Session Information
Date: Thursday, June 8, 2017
Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology
Session Time: 1:15pm-2:45pm
Location: Exhibit Hall C
Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and PET molecular imaging with [11C]rolipram in Parkinson’s disease (PD).
Background: Sleep disturbances are very common in patients with PD. Animal and genome-wide association studies have suggested a link between cAMP/PKA signalling, PDE4 expression (an enzyme which hydrolyses cAMP) and daytime sleepiness.
Methods: 12 PD patients and 5 healthy controls underwent clinical and imaging assessments. Sleep disturbances were assessed with the Parkinson’s disease sleep scale (PDSS), Epworth Sleepiness Scale (ESS) a measure of excessive daytime sleepiness (EDS), UPDRS-I single items for sleep and fatigue, and non-motor symptom scale (NMSS) domain 2 sleep/fatigue. MIAKATTM was used to generate parametric images of [11C]rolipram volume of distribution (VT) with the Logan plot. FMRIB’s diffusion toolbox (FDT) was used to perform probabilistic tractography on each subjects’ diffusion data to functionally parcellate the striatum according to cortico-striatal projections to generate connectivity maps for limbic, cognitive and sensorimotor subdivisions of the striatum.
Results: PD patients with EDS had significantly increased VT values compared to those without EDS. Higher ESS scores, indicating greater EDS, correlated with higher PDE4 VT in cortical regions involved in the limbic loop [amygdala (r=0.670), hippocampus (r=0.813), orbitofrontal (r=0.685), cingulate (r=0.663) and temporal cortex (r=0.809)], striatum (0.713), thalamus (r=0.660), hypothalamus (r=0.819) and accumbens (r=0.738). Furthermore, higher EDS was associated with specific increases in PDE4 within limbic portions of the striatum (connectivity based analysis, (r=0.788).
Conclusions: Our findings indicate converging evidence for an association between daytime sleepiness and elevated PDE4 in cortical and subcortical limbic regions, implicating PDE4 in the pathophysiology of sleep disturbances in PD.
To cite this abstract in AMA style:
H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis. The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/the-role-of-phosphodiesterase-4-in-sleep-disturbances-in-parkinsons-disease/. Accessed November 22, 2024.« Back to 2017 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/the-role-of-phosphodiesterase-4-in-sleep-disturbances-in-parkinsons-disease/